Dennis A Eichenauer
Overview
Explore the profile of Dennis A Eichenauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
1489
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eichenauer D, Borchmann P
Leuk Lymphoma
. 2025 Jan;
:1-8.
PMID: 39743924
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma entity accounting for ≈5% of all Hodgkin lymphoma (HL) cases. As some characteristics of NLPHL resemble B-cell non-Hodgkin lymphoma (B-NHL), nodular...
2.
Caspers A, Pralong A, Hallek M, Voltz R, Simon S, Eichenauer D
Hematol Oncol
. 2024 Dec;
43(1):e70021.
PMID: 39655715
No abstract available.
3.
Goldkuhle M, Kreuzberger N, von Tresckow B, Eichenauer D, Specht L, Monsef I, et al.
Cochrane Database Syst Rev
. 2024 Dec;
12:CD007110.
PMID: 39620432
Background: Early-stage Hodgkin's lymphoma in adults is commonly treated with combined modality treatment of chemotherapy followed by radiotherapy. The role of radiotherapy has been questioned due to potential long-term adverse...
4.
Caspers A, Eichenauer D, Pralong A, Simon S
J Palliat Med
. 2024 Sep;
28(1):26-34.
PMID: 39344793
Data on the involvement of hospital palliative care teams (HPCT) in the management of patients with hematologic malignancies (HM) are limited. To describe characteristics, symptom burden according to the German...
5.
Neumann M, Naendrup J, Garcia Borrega J, Halmer I, Altenrath L, Sieg N, et al.
Hematol Oncol
. 2024 Aug;
42(5):e3300.
PMID: 39138851
The overall prognosis of older patients with acute myeloid leukemia (AML) is dismal. Only a small subgroup experiences long-term survival. The discrimination between patients who are candidates for potentially curative...
6.
Liedgens P, Heger J, Sieg N, Garcia Borrega J, Naendrup J, Simon F, et al.
Eur J Haematol
. 2024 Jun;
113(4):493-500.
PMID: 38937785
Objectives: To investigate characteristics and outcomes of critically ill cancer patients with marked hyperferritinemia. Methods: A single-center retrospective analysis comprising cancer patients with a ferritin level >10.000 μg/L treated in...
7.
Neumann M, Sieg N, Garcia Borrega J, Huser C, Caspers M, Shimabukuro-Vornhagen A, et al.
Med Klin Intensivmed Notfmed
. 2024 Jun;
PMID: 38916655
Background: Direct oral anticoagulants (DOAC) are increasingly used for prophylaxis and treatment of thromboembolic events. Incorrectly dosed DOAC treatment is associated with excess mortality. Purpose: This article aims at raising...
8.
Kuhne L, Knobl P, Eller K, Thaler J, Sperr W, Gleixner K, et al.
Blood
. 2024 Jun;
144(14):1486-1495.
PMID: 38838300
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare, life-threatening autoimmune disorder caused by a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13 (ADAMTS13) deficiency. Caplacizumab, an anti-von Willebrand...
9.
Rosenbrock J, Kaul H, Oertel M, Celik E, Linde P, Fan J, et al.
Int J Radiat Oncol Biol Phys
. 2024 Apr;
120(5):1344-1352.
PMID: 38631539
Purpose: Combined modality treatment with chemotherapy followed by consolidation radiation therapy (RT) provides excellent outcomes for patients with early-stage Hodgkin lymphoma. The international standard of care for consolidation RT, involved-site/involved-node...
10.
Gebel C, Kruschel I, Bodinger S, Simon S, Eichenauer D, Pralong A, et al.
Ann Hematol
. 2024 Mar;
103(5):1753-1763.
PMID: 38538976
Integrating palliative care into the treatment of patients with advanced hematological malignancies (HM) remains challenging. To explore treating physicians' perspectives on current palliative care practice and to evaluate factors influencing...